2019
DOI: 10.1016/s0618-8278(19)31167-3
|View full text |Cite
|
Sign up to set email alerts
|

FRI-430-Preclinical validation of copper 64 as a translational tool for evaluating the pharmacodynamics of VTX-801 genen therapy in Wilson’s disease

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles